Longer survival of advanced cancer patients given methylnaltrexone for constipation suggests role for mu opiate receptor in cancer progression
Saturday, September 3, 2016 - 05:01
in Health & Medicine
Opioid painkillers and their receptor in cells -- the mu opiate receptor -- could be involved in cancer progression, and could thus be a target for treatments, a study of advanced cancer patients suggests.